Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

Regulation of Food Intake

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...

cAMP-dependent Protein Kinase Pathways

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The development and impact of an innovative graduate program to promote entry to physiology-related careers: the Master of Health Science in Medical Physiology.

Advances in physiology education·2026

Same author

Utilizing a human TLR selective ligand in a humanized immune system mouse model to investigate human TLR4 signaling.

Journal of biological methods·2023

Same author

A New Role for Endocrine Cells in the Intestinal Crypt.

Cellular and molecular gastroenterology and hepatology·2023

Same author

The Molecular Determinants of Glucagon-like Peptide Secretion by the Intestinal L cell.

Endocrinology·2022

Same author

Disrupted and Elevated Circadian Secretion of Glucagon-Like Peptide-1 in a Murine Model of Type 2 Diabetes.

Endocrinology·2022

Same author

Nobiletin ameliorates high fat-induced disruptions in rhythmic glucagon-like peptide-1 secretion.

Scientific reports·2022

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells

Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells

Published on: April 20, 2017

Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators.

Philip E Dubé¹, Patricia L Brubaker

¹Department of Physiology, University of Toronto, Toronto, Ontario, Canada.

American Journal of Physiology. Endocrinology and Metabolism

|July 27, 2007

Summary

Glucagon-like peptide-2 (GLP-2) impacts intestinal health through complex signaling. Research reveals indirect mediators like IGF-1 and KGF are crucial for GLP-2

More Related Videos

Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine

Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine

Published on: February 26, 2019

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

Related Experiment Videos

Last Updated: Jul 13, 2026

Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells

Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells

Published on: April 20, 2017

Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine

Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine

Published on: February 26, 2019

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

Area of Science:

Gastroenterology
Molecular Biology
Endocrinology

Background:

Glucagon-like peptide-2 (GLP-2) is a hormone influencing intestinal growth, barrier function, and nutrient absorption.
Its complex mechanisms involve unique signaling pathways and indirect mediators.
Understanding these pathways is vital as GLP-2 therapies are explored for intestinal disorders.

Purpose of the Study:

To elucidate the complex mechanisms of GLP-2 action in intestinal physiology.
To identify the indirect mediators involved in GLP-2's biological effects.
To understand GLP-2 receptor (GLP-2R) signaling and trafficking.

Main Methods:

Review of existing literature on GLP-2 signaling and receptor function.
Analysis of studies investigating indirect mediators of GLP-2 action.
Examination of GLP-2R expression in various intestinal cell types.

Main Results:

GLP-2R signals through G proteins, affecting cAMP and MAPK pathways, promoting cell proliferation and survival.
GLP-2 acts indirectly, requiring mediators such as insulin-like growth factor I (IGF-1) for crypt cell proliferation.
Vasoactive intestinal polypeptide (VIP) and keratinocyte growth factor (KGF) modulate GLP-2 actions in inflammation and mucosal growth, respectively.

Conclusions:

GLP-2 exerts pleiotropic effects on the intestine through intricate signaling networks.
Indirect mediators, including IGF-1, VIP, and KGF, play critical roles in mediating GLP-2's diverse functions.
Further research is needed to fully map GLP-2's biological effects and interacting mediators.